invenious™ for pharma companies
The invenious™ platform transforms infusible drugs into a
‘connect-and-go’ package
invenious™ offers multiple benefits to pharmaceutical companies.
For pharmaceutical companies seeking fast, efficient ways to unlock extra revenue growth, the invenious™ platform could offer a safe, proven and more efficient alternative to reformulation. Invenious™ infusion systems does this for:
- Infusible medicines whose market performance is held back by complex preparation and administration
- Products approaching loss of exclusivity
Together, this means the invenious™ platform could help you:
- Differentiate each therapeutic application against competitors
- Gain opportunities for lifecycle management
- Build on existing product claims with new benefits to administration like cost effectiveness, efficiency, and safety
- Provide tangible advantages over competing products with similar efficacy
The invenious™ team has done it before
invenious™ connect-and-go technology is already being used to deliver infusibles in a patented range of infusion systems. Our products are thoughtfully-designed to each drug – with bespoke solutions for:
- Drugs requiring complex weight-based dosing
- Cytotoxic drugs
- Drugs that need to be reconstituted or diluted at time of use
- Drug-drug combinations, including for cold-chain products
BioQ Pharma has a proven track record of delivering drug-device combination product approvals around the world. With our proprietary technology, and pharmaceutical and device know-how, we can take invenious™ to where it’s needed.